Literature DB >> 21706476

Importance of specimen length during temporal artery biopsy.

E Ypsilantis1, E D Courtney, N Chopra, A Karthikesalingam, M Eltayab, N Katsoulas, T Y Tang, R Y Ball.   

Abstract

BACKGROUND: Variations in surgical technique of temporal artery biopsy (TAB) performed for diagnosis of giant cell arteritis (GCA) may contribute to high false-negative rates. This was a retrospective analysis of a large database that explored potential associations between specimen length and diagnostic sensitivity of TAB.
METHODS: Histopathological reports and medical records of patients who underwent TAB in six hospitals between 2004 and 2009 were reviewed.
RESULTS: A total of 966 biopsies were analysed. The median postfixation specimen length was 1 (range 0·1-8·5) cm and 207 biopsies (21·4 per cent) were positive for GCA. Significant variation in prebiopsy erythrocyte sedimentation rate (ESR), arterial specimen length and positive results was noted amongst hospitals. Multivariable analysis revealed that patient age, ESR value and specimen length were independent predictors of GCA. Positive biopsies had significantly longer median specimen length compared with negative biopsies: 1·2 (range 0·3-8·5) versus 1·0 (0·2-8·0) cm respectively (P = 0·001). Receiver operating characteristic (ROC) analysis identified postfixation specimen length of at least 0·7 cm as the cut-off length with highest positive predictive value for a positive biopsy (area under ROC curve 0·574). Biopsies with specimen length of 0·7 cm or more had a significantly higher rate of positive results than smaller specimens (24·8 versus 12·9 per cent respectively; odds ratio 2·17, P = 0·001).
CONCLUSION: Specimen length and ESR were independent prognostic factors of a positive TAB result. A uniform referral practice and standard specimen length of approximately 1 cm could help eliminate discrepancies in the results of TAB.
Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21706476     DOI: 10.1002/bjs.7595

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

Review 1.  Facial nerve injury during temporal artery biopsy.

Authors:  A R Gunawardene; H Chant
Journal:  Ann R Coll Surg Engl       Date:  2014-05       Impact factor: 1.891

2.  A study of temporal artery biopsy for the diagnosis of giant cell arteritis.

Authors:  Ronald Butendieck; Kenneth Calamia; Adam Sandin
Journal:  Clin Rheumatol       Date:  2022-09-12       Impact factor: 3.650

3.  Temporal artery biopsy for giant cell arteritis: retrospective audit.

Authors:  Habiba Saedon; Mahmud Saedon; Steve Goodyear; Trifonas Papettas; Colette Marshall
Journal:  JRSM Short Rep       Date:  2012-10-22

4.  Paroxysmal hemicrania as the clinical presentation of giant cell arteritis.

Authors:  Jennifer L Beams; Todd D Rozen
Journal:  Clin Pract       Date:  2011-11-09

5.  Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation.

Authors:  Edsel B Ing; Neil R Miller; Angeline Nguyen; Wanhua Su; Lulu L C D Bursztyn; Meredith Poole; Vinay Kansal; Andrew Toren; Dana Albreki; Jack G Mouhanna; Alla Muladzanov; Mikaël Bernier; Mark Gans; Dongho Lee; Colten Wendel; Claire Sheldon; Marc Shields; Lorne Bellan; Matthew Lee-Wing; Yasaman Mohadjer; Navdeep Nijhawan; Felix Tyndel; Arun N E Sundaram; Martin W Ten Hove; John J Chen; Amadeo R Rodriguez; Angela Hu; Nader Khalidi; Royce Ing; Samuel W K Wong; Nurhan Torun
Journal:  Clin Ophthalmol       Date:  2019-02-21

6.  The Adequate Number of Histopathology Cross-sections of Temporal Artery Biopsy in Establishing the Diagnosis of Giant Cell Arteritis.

Authors:  Roshanak Ali-Akbar Navahi; Samira Chaibakhsh; Sayyed Amirpooya Alemzadeh; Kaveh Abri Aghdam
Journal:  J Ophthalmic Vis Res       Date:  2021-01-20

7.  Multivariable prediction model for suspected giant cell arteritis: development and validation.

Authors:  Edsel B Ing; Gabriela Lahaie Luna; Andrew Toren; Royce Ing; John J Chen; Nitika Arora; Nurhan Torun; Otana A Jakpor; J Alexander Fraser; Felix J Tyndel; Arun Ne Sundaram; Xinyang Liu; Cindy Ty Lam; Vivek Patel; Ezekiel Weis; David Jordan; Steven Gilberg; Christian Pagnoux; Martin Ten Hove
Journal:  Clin Ophthalmol       Date:  2017-11-22

8.  Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.

Authors:  Sara Monti; Ana F Águeda; Raashid Ahmed Luqmani; Frank Buttgereit; Maria Cid; Christian Dejaco; Alfred Mahr; Cristina Ponte; Carlo Salvarani; Wolfgang Schmidt; Bernhard Hellmich
Journal:  RMD Open       Date:  2019-09-16

Review 9.  Temporal Artery Biopsy for Diagnosing Giant Cell Arteritis: A Ten-year Review.

Authors:  Kaveh Abri Aghdam; Mostafa Soltan Sanjari; Navid Manafi; Shabnam Khorramdel; Sayyed Amirpooya Alemzadeh; Roshanak Ali Akbar Navahi
Journal:  J Ophthalmic Vis Res       Date:  2020-04-06

10.  Boundaries of a systemic disease: a protean presentation of giant cell arteritis.

Authors:  António Mesquita; Lara Camara; Catarina Patrício; Vítor Brotas
Journal:  BMJ Case Rep       Date:  2020-03-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.